TY  - GEN
AU  - Coles,A J
AU  - Wing,M G
AU  - Molyneux,P
AU  - Paolillo,A
AU  - Davie,C M
AU  - Hale,G
AU  - Miller,D
AU  - Waldmann,H
AU  - Compston,A
TI  - Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis
SN  - 0364-5134
PY  - 1999///1020
KW  - Adult
KW  - Alemtuzumab
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Humanized
KW  - Antibodies, Neoplasm
KW  - Enzyme-Linked Immunosorbent Assay
KW  - Humans
KW  - Inflammation
KW  - pathology
KW  - Magnetic Resonance Imaging
KW  - Multiple Sclerosis
KW  - Time Factors
KW  - Tumor Necrosis Factor-alpha
KW  - analysis
N1  - Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/1531-8249(199909)46:3<296::aid-ana4>3.0.co;2-#
ER  -